Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PSX1002
- Development stage
- Unknown
- Lead developer
- NIOX
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Administration
- Inhalation
01
Overview
PSX1002 is a novel, particle-engineered, drug-only suspension formulation of glycopyrronium bromide (GB), a long-acting muscarinic antagonist (LAMA). It is designed for oral inhalation via a pressurized metered dose inhaler (pMDI) and developed using Prosonix’s proprietary particle engineering technology. The formulation does not require any extraneous carriers or functional excipients. PSX1002 was developed as a potential once-daily, best-in-class monotherapy for moderate to severe chronic obstructive pulmonary disease (COPD). Clinical studies have shown that single doses of PSX1002 produce rapid bronchodilation within 5 minutes and sustained improvement in lung function over 24 hours, with good tolerability and safety profiles comparable to placebo[1][3][4][7].
- Other names
- PSX1002-GBPSX-1002-GBPSX 1002-GB
02
Targets
CHRM3 (M3)
Beyond the preview
Go deeper on PSX1002.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PSX1002.